Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial
Titel:
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial
Auteur:
Verschoor, Noortje Bos, Manouk K. de Kruijff, Ingeborg E. Van, Mai N. Kraan, Jaco Drooger, Jan C. Zuetenhorst, Johanna M. Wilting, Saskia M. Sleijfer, Stefan Jager, Agnes Martens, John W. M.